How Is Chronic Obstructive Pulmonary Disease Treated?
Although there is no cure for COPD, the disease can be prevented
in many cases. And, in almost all cases the disabling symptoms
can be reduced. Because cigarette smoking is the most important
cause of COPD, not smoking almost always prevents COPD from
developing, and quitting smoking slows the disease process.
There is no cure for COPD at present, but the disease is
usually preventable.
If the patient and medical team develop and adhere to a
program of complete respiratory care, disability can be
minimized, acute episodes prevented, hospitalizations reduced,
and some early deaths avoided. On the other hand, none of
the therapies has been shown to slow the progression of
the disease, and only oxygen therapy has been shown to increase
the survival rate.
Home oxygen therapy can improve survival of COPD patients.
Home oxygen therapy can improve survival in patients with
advanced COPD who have hypoxemia, low blood oxygen levels.
This treatment can improve a patient's exercise tolerance
and ability to perform on psychological tests which reflect
different aspects of brain function and muscle coordination.
Increasing the concentration of oxygen in blood also improves
the function of the heart and prevents the development of
cor pulmonale. Oxygen can also lessen sleeplessness, irritability,
headaches, and the overproduction of red blood cells. Continuous
oxygen therapy is recommended for patients with low oxygen
levels at rest, during exercise, or while sleeping. Many
oxygen sources are available for home use; these include
tanks of compressed gaseous oxygen or liquid oxygen and
devices that concentrate oxygen from room air. However,
oxygen is expensive with the cost per patient running into
several hundred dollars per month, depending on the type
of system and on the locale.
Medications frequently prescribed for COPD patients include:
Bronchodilators help open narrowed airways. There are three
main categories: sympathomimetics (isoproterenol, metaproterenol,
terbutaline, albuterol) which can be inhaled, injected,
or taken by mouth; parasympathomimetics (atropine, ipratropium
bromide); and methylxanthines (theophylline and its derivatives)
which can be given intravenously, orally, or rectally.
Corticosteroids or steroids (beclomethasone, dexamethasone,
triamcinolone, flunisolide) lessen inflammation of the airway
walls. They are sometimes used if airway obstruction cannot
be kept under control with bronchodilators, and lung function
is shown to improve on this therapy. Inhaled steroids given
regularly may be of benefit in some patients and have few
side effects.
Antibiotics (tetracycline, ampicillin, erythromycin, and
trimethoprim-sulfamethoxazole combinations) fight infection.
They are frequently given at the first sign of a respiratory
infection such as increased sputum production with a change
in color of sputum from clear to yellow or green.
Expectorants help loosen and expel mucus secretions from
the airways.
Diuretics help the body excrete excess fluid. They are
given as therapy to avoid excess water retention associated
with right-heart failure. Patients taking diuretics are
monitored carefully because dehydration must be avoided.
These drugs also may cause potassium imbalances which can
lead to abnormal heart rhythms.
Digitalis (usually in the form of digoxin) strengthens
the force of the heartbeat. It is used very cautiously in
patients who have COPD, especially if their blood oxygen
tensions are low, because they are vulnerable to abnormal
heart rhythms when taking this drug.
Other drugs sometimes taken by patients with COPD are tranquilizers,
pain killers (meperidine, morphine, propoxyphene, etc.),
cough suppressants (codeine, etc.), and sleeping pills (barbiturates,
etc.). All these drugs depress breathing to some extent;
they are avoided whenever possible and used only with great
caution.
A number of combination drugs containing various assortments
of sympathomimetics, methylxanthines, expectorants, and
sedatives are marketed and widely advertised. These drugs
are undesirable for COPD patients for several reasons. It
is difficult to adjust the dose of methylxanthines without
getting interfering side effects from the other ingredients.
The sympathomimetic drug used in these preparations is ephedrine,
a drug with many side effects and less bronchodilating effect
than other drugs now available. The combination drugs often
contain sedatives to combat the unpleasant side effects
of ephedrine. They also contain expectorants which have
not been proven to be effective for all patients and may
have some side effects.
Bullectomy, or surgical removal of large air spaces called
bullae that are filled with stagnant air, may be beneficial
in selected patients. Recently, use of lasers to remove
bullae has been suggested.
Lung transplantation has been successfully employed in
some patients with end-stage COPD. In the hands of an experienced
team, the 1-year survival in patients with transplanted
lungs is over 70 percent.
Pulmonary rehabilitation programs, along with medical treatment,
are useful in certain patients with COPD. The goals are
to improve overall physical endurance and generally help
to overcome the conditions which cause dyspnea and limit
capacity for physical exercise and activities of daily living.
General exercise training increases performance, maximum
oxygen consumption, and overall sense of well-being. Administration
of oxygen and nutritional supplements when necessary can
improve respiratory muscle strength. Intermittent mechanical
ventilatory support relieves dyspnea and rests respiratory
muscles in selected patients. Continuous positive airway
pressure (CPAP) is used as an adjunct to weaning from mechanical
ventilation to minimize dyspnea during exercise. Relaxation
techniques may also reduce the perception of ventilatory
effort and dyspnea. Breathing exercises and breathing techniques,
such as pursed lips breathing and relaxation, improve functional
status.
Keeping air passages reasonably clear of secretions is
difficult for patients with advanced COPD. Some commonly
used methods for mobilizing and removing secretions are
the following:
Postural bronchial drainage helps to remove secretions from
the airways. The patient lies in prescribed positions that
allow gravity to drain different parts of the lung. This
is usually done after inhaling an aerosol. In the basic
position, the patient lies on a bed with his chest and head
over the side and his forearms resting on the floor.
Chest percussion or lightly clapping the chest and back,
may help dislodge tenacious or copious secretions.
Controlled coughing techniques are taught to help the patient
bring up secretions.
Bland aerosols, often made from solutions of salt or bicarbonate
of soda, are inhaled. These aerosols thin and loosen secretions.
Treatments usually last 10 to 15 minutes and are taken three
or four times a day. Bronchodilators are sometimes added
to the aerosols.